71.50
price down icon0.20%   -0.14
after-market 시간 외 거래: 72.00 0.50 +0.70%
loading
전일 마감가:
$71.64
열려 있는:
$71.23
하루 거래량:
1.47M
Relative Volume:
0.60
시가총액:
$11.40B
수익:
$705.14M
순이익/손실:
$-453.90M
주가수익비율:
-23.52
EPS:
-3.04
순현금흐름:
$-551.29M
1주 성능:
-1.23%
1개월 성능:
+16.53%
6개월 성능:
+146.30%
1년 성능:
+84.85%
1일 변동 폭
Value
$70.60
$71.98
1주일 범위
Value
$70.47
$74.42
52주 변동 폭
Value
$23.95
$74.42

Ionis Pharmaceuticals Inc Stock (IONS) Company Profile

Name
명칭
Ionis Pharmaceuticals Inc
Name
전화
(760) 931-9200
Name
주소
2855 GAZELLE COURT, CARLSBAD, CA
Name
직원
927
Name
트위터
@ionispharma
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
IONS's Discussions on Twitter

IONS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IONS
Ionis Pharmaceuticals Inc
71.50 11.42B 705.14M -453.90M -551.29M -3.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.44 109.29B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.90 62.13B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
584.74 61.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
814.17 51.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.54 34.68B 4.56B -176.77M 225.30M -1.7177

Ionis Pharmaceuticals Inc Stock (IONS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-10-08 업그레이드 JP Morgan Neutral → Overweight
2025-09-26 업그레이드 Goldman Sell → Neutral
2025-09-03 업그레이드 BMO Capital Markets Market Perform → Outperform
2025-07-31 업그레이드 Morgan Stanley Equal-Weight → Overweight
2025-07-01 업그레이드 Barclays Equal Weight → Overweight
2025-04-07 개시 H.C. Wainwright Buy
2025-03-31 개시 Redburn Atlantic Neutral
2024-08-02 다운그레이드 BMO Capital Markets Outperform → Market Perform
2024-07-24 업그레이드 Leerink Partners Market Perform → Outperform
2024-07-16 재개 Jefferies Buy
2024-06-14 업그레이드 Bernstein Underperform → Mkt Perform
2024-04-10 업그레이드 Wolfe Research Peer Perform → Outperform
2024-01-02 업그레이드 BofA Securities Neutral → Buy
2023-10-23 업그레이드 BofA Securities Underperform → Neutral
2023-09-29 개시 Raymond James Strong Buy
2023-07-31 업그레이드 Citigroup Neutral → Buy
2023-06-07 재개 Piper Sandler Overweight
2023-05-04 업그레이드 Citigroup Sell → Neutral
2023-03-21 개시 Bernstein Underperform
2022-12-21 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2022-09-09 재개 Morgan Stanley Overweight
2022-07-18 재개 Oppenheimer Outperform
2022-03-31 재개 Piper Sandler Overweight
2022-03-01 개시 Citigroup Sell
2022-03-01 개시 Guggenheim Buy
2022-02-01 다운그레이드 BofA Securities Buy → Underperform
2021-12-14 업그레이드 William Blair Mkt Perform → Outperform
2021-05-07 업그레이드 UBS Sell → Neutral
2021-03-01 업그레이드 Barclays Underweight → Equal Weight
2020-12-16 개시 UBS Sell
2020-12-15 업그레이드 Cowen Market Perform → Outperform
2020-09-14 재개 JP Morgan Neutral
2020-09-02 개시 The Benchmark Company Hold
2020-06-01 재개 Oppenheimer Outperform
2020-05-13 개시 RBC Capital Mkts Outperform
2020-03-05 개시 Citigroup Buy
2019-12-13 개시 Oppenheimer Outperform
2019-11-13 개시 BofA/Merrill Buy
2019-11-07 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2019-09-10 업그레이드 Bernstein Mkt Perform → Outperform
2018-08-08 재확인 Stifel Hold
2018-08-07 재확인 Stifel Hold
2018-05-08 다운그레이드 Evercore ISI Outperform → In-line
2017-10-06 재개 Goldman Sell
2017-08-17 개시 Evercore ISI Outperform
2017-08-09 재확인 Stifel Hold
2017-03-10 다운그레이드 Goldman Neutral → Sell
2016-12-28 재확인 BMO Capital Markets Outperform
2016-12-27 재확인 Leerink Partners Mkt Perform
모두보기

Ionis Pharmaceuticals Inc 주식(IONS)의 최신 뉴스

pulisher
10:00 AM

Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance

10:00 AM
pulisher
12:40 PM

What is the fair value estimate for Ionis Pharmaceuticals Inc. (ISI) stock in 20252025 Fundamental Recap & High Accuracy Investment Signals - newser.com

12:40 PM
pulisher
Oct 21, 2025

Published on: 2025-10-21 21:59:51 - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Can Ionis Pharmaceuticals Inc. (ISI) stock sustain revenue momentumBond Market & Real-Time Stock Entry Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Sector ETF performance correlation with Ionis Pharmaceuticals Inc.Portfolio Risk Summary & Technical Pattern Based Buy Signals - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Ionis CEO Brett P. Monia receives 2025 Lifetime Achievement Award from the Oligonucleotide Therapeutics Society - Business Wire

Oct 21, 2025
pulisher
Oct 21, 2025

Is Ionis Pharmaceuticals Inc. stock poised for growth2025 Price Momentum & Weekly Hot Stock Watchlists - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Published on: 2025-10-21 01:16:00 - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Ionis Pharmaceuticals Inc. stock trend outlook and recovery pathJuly 2025 Sentiment & Scalable Portfolio Growth Ideas - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Can Ionis Pharmaceuticals Inc. stock resist market sell offsNew Guidance & Community Trade Idea Sharing - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Capricorn Buys New Stake in Ionis Pharmaceuticals (IONS) With 163,000 Shares - The Motley Fool

Oct 20, 2025
pulisher
Oct 20, 2025

News impact scoring models applied to Ionis Pharmaceuticals Inc.July 2025 Sentiment & Accurate Technical Buy Alerts - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Is Ionis Pharmaceuticals Inc. (ISI) stock resilient in recession scenariosIPO Watch & Verified Technical Signals - nchmf.gov.vn

Oct 20, 2025
pulisher
Oct 20, 2025

Can you recover from losses in Ionis Pharmaceuticals Inc.Portfolio Return Report & Smart Allocation Stock Tips - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Is Ionis Pharmaceuticals Inc. stock ready for breakoutJuly 2025 Outlook & Consistent Profit Alerts - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Will Ionis Pharmaceuticals Inc. stock deliver better than expected guidanceTrade Ideas & Verified Technical Signals - newser.com

Oct 20, 2025
pulisher
Oct 19, 2025

Is Ionis Pharmaceuticals Inc. building a consolidation baseEarnings Performance Report & Weekly High Return Stock Forecasts - newser.com

Oct 19, 2025
pulisher
Oct 19, 2025

Why ETFs are accumulating Ionis Pharmaceuticals Inc. (ISI) stockGold Moves & Safe Capital Allocation Plans - newser.com

Oct 19, 2025
pulisher
Oct 18, 2025

What recovery options are there for Ionis Pharmaceuticals Inc.July 2025 Setups & Detailed Earnings Play Strategies - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

Should Ionis Pharmaceuticals' (IONS) Raised Revenue Guidance and Strong Q2 Results Prompt Investor Action? - Sahm

Oct 18, 2025
pulisher
Oct 18, 2025

Can Ionis Pharmaceuticals Inc. stock weather global recessionTrade Exit Summary & Technical Entry and Exit Tips - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Layoff Watch: Can Ionis Pharmaceuticals Inc. stock weather global recessionJuly 2025 PostEarnings & Stepwise Trade Signal Guides - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

Will Ionis Pharmaceuticals Inc. stock sustain high P E ratiosRecession Risk & Advanced Swing Trade Entry Plans - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Bear Alert: Is Ionis Pharmaceuticals Inc. stock a top pick in earnings seasonQuarterly Trade Report & Smart Money Movement Tracker - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Hedge Fund and Insider Trading News: Scott Bessent, Paul Tudor Jones, Crispin Odey, Ken Griffin, Millennium Management, Ionis Pharmaceutical Inc (IONS), Chicago Atlantic Real Estate Finance Inc (REFI), and More - Insider Monkey

Oct 17, 2025
pulisher
Oct 17, 2025

CapEx per share of Ionis Pharmaceuticals, Inc. – DUS:ISI - TradingView

Oct 17, 2025
pulisher
Oct 17, 2025

Ionis Pharmaceuticals Insider Sold Shares Worth $1,723,987, According to a Recent SEC Filing - MarketScreener

Oct 17, 2025
pulisher
Oct 16, 2025

Ionis Pharmaceuticals director Parshall sells $358,721 in stock By Investing.com - Investing.com Australia

Oct 16, 2025
pulisher
Oct 16, 2025

Ionis Pharmaceuticals EVP Birchler sells $1.72m in shares By Investing.com - Investing.com Australia

Oct 16, 2025
pulisher
Oct 16, 2025

Insider Sell Alert: B Parshall Sells 5,000 Shares of Ionis Pharm - GuruFocus

Oct 16, 2025
pulisher
Oct 16, 2025

Ionis Pharma EVP Devers sells shares worth $530,636 By Investing.com - Investing.com Canada

Oct 16, 2025
pulisher
Oct 16, 2025

Ionis Pharmaceuticals EVP research, Eric Swayze, sells $3901 in IONS stock - Investing.com Nigeria

Oct 16, 2025
pulisher
Oct 16, 2025

Ionis Pharmaceuticals EVP Birchler sells $1.72m in shares - Investing.com

Oct 16, 2025
pulisher
Oct 16, 2025

Morgan Stanley Raises Price Target for Ionis Pharmaceuticals (IO - GuruFocus

Oct 16, 2025
pulisher
Oct 16, 2025

Ionis Pharmaceuticals Hits New 52-Week High of $72.15 - Markets Mojo

Oct 16, 2025
pulisher
Oct 16, 2025

Ionis Pharmaceuticals Hits New 52-Week High of $73.92 - Markets Mojo

Oct 16, 2025
pulisher
Oct 16, 2025

Morgan Stanley Raises Price Target on Ionis Pharmaceuticals to $90 From $86, Keeps Overweight Rating - MarketScreener

Oct 16, 2025
pulisher
Oct 16, 2025

Ionis to hold third quarter 2025 financial results webcast - FinancialContent

Oct 16, 2025
pulisher
Oct 16, 2025

Lobbying Update: $140,000 of IONIS PHARMACEUTICALS INC. lobbying was just disclosed - Quiver Quantitative

Oct 16, 2025

Ionis Pharmaceuticals Inc (IONS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$36.84
price down icon 1.71%
$88.06
price up icon 0.87%
$29.92
price down icon 0.70%
$106.23
price down icon 0.62%
$160.40
price down icon 2.97%
biotechnology ONC
$313.54
price down icon 0.70%
자본화:     |  볼륨(24시간):